Literature DB >> 5082464

The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.

R M Carey, J G Douglas, J R Schweikert, G W Liddle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5082464

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  26 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Aldosterone to renin ratio as a predictor of diuretic response.

Authors:  Steven A Atlas
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

3.  Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.

Authors:  P O Lim; R T Jung; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

4.  Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.

Authors:  R Fagard; A Amery; P Lijnen; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

Review 5.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

6.  Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.

Authors:  R M Carey; C R Ayers; E D Vaughan; M J Peach; S M Herf
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

7.  [Antihypertensive effect of spironolactone (author's transl)].

Authors:  H Liebau; W Jarosch-von Schweder
Journal:  Klin Wochenschr       Date:  1974-09-01

8.  Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension.

Authors:  Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Maria Plonczynski; Celso E Gomez-Sanchez
Journal:  Exp Physiol       Date:  2009-10-16       Impact factor: 2.969

9.  Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.

Authors:  B I Hoffbrand; C J Edmonds; T Smith
Journal:  Br Med J       Date:  1976-03-20

10.  Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.

Authors:  B E Karlberg; B Kågedal; L Tegler; K Tolagen
Journal:  Br Med J       Date:  1976-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.